Transesophageal ECHO Impacts Cardioembolic Stroke Care

This article originally appeared here.
Share this content:
Transesophageal ECHO Impacts Cardioembolic Stroke Care
Transesophageal ECHO Impacts Cardioembolic Stroke Care

MONDAY, Dec. 15, 2014 (HealthDay News) -- As a result of transesophageal echocardiography (TEE) for suspected cardioembolic stroke, 16.7 percent of patients experience a significant change in management, according to a study published in the Dec. 15 issue of The American Journal of Cardiology.

Yevgeniy Khariton, M.D., from Saint Luke's Mid America Heart Institute in Kansas City, Mo., and colleagues examined the clinical impact of TEE on management in a retrospective single-center study. Participants included 1,458 consecutive patients hospitalized with acute ischemic stroke or transient ischemic attack who underwent TEE evaluation.

The researchers found that there was a significant change in management (including initiation of anticoagulation, placement of a patent foramen ovale [PFO] closure device, initiation of antibiotic therapy for endocarditis, surgical PFO closure, other cardiac surgery, and coil embolization of a pulmonary arteriovenous malformation) in 16.7 percent of patients. Of these, 71 percent underwent treatment for PFO with a percutaneous PFO closure device, initiation of chronic systemic anticoagulation, or surgical PFO closure. There was a change in management with additional findings, including endocarditis, aortic arch atheroma, intracardiac thrombus, pulmonary arteriovenous malformation, aortic valve fibroelastoma, other valve masses, and miscellaneous causes.

"In conclusion, in patients with suspected cardioembolic stroke, TEE findings led to a change in management in 16.7 percent of patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »